Syverson Strege & CO Viatris Inc Transaction History

Syverson Strege & CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$9.2 - $12.26 $1,223 - $1,630	133 Added 237.5%	189 $1,000
Q4 2022 Feb 06, 2023	SELL	$8.72 - $11.56 $994 - $1,317	-114 Reduced 67.06%	56 $0
Q3 2022 Nov 09, 2022	BUY	$8.48 - $11.13 $16 - $22	2 Added 1.19%	170 $1,000
Q2 2022 Aug 11, 2022	SELL	$9.95 - $12.27 $228 - $282	-23 Reduced 12.04%	168 $2,000
Q1 2022 Apr 13, 2022	BUY	$9.81 - $15.4 $9 - $15	1 Added 0.53%	191 $2,000
Q4 2021 Jan 19, 2022	SELL	$12.09 - $14.68 $2,937 - $3,567	-243 Reduced 56.12%	190 $3,000
Q3 2021 Nov 02, 2021	BUY	$13.25 - $15.13 $3,246 - $3,706	245 Added 130.32%	433 $6,000
Q2 2021 Aug 04, 2021	BUY	$12.97 - $16.15 $324 - $403	25 Added 15.34%	188 $3,000
Q4 2020 Feb 03, 2021	BUY	$14.3 - $18.74 $2,330 - $3,054	163 New	163 $3,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Syverson Strege & CO, based on Form 13F filings with the SEC.

Stay updated on Syverson Strege & CO with notifications on news.